D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Apple
AAPL
|
+$315M |
| 2 |
Exxon Mobil
XOM
|
+$312M |
| 3 |
Verizon
VZ
|
+$289M |
| 4 |
Procter & Gamble
PG
|
+$288M |
| 5 |
Pfizer
PFE
|
+$272M |
Top Sells
| 1 |
Tesla
TSLA
|
+$619M |
| 2 |
Biogen
BIIB
|
+$369M |
| 3 |
Amazon
AMZN
|
+$341M |
| 4 |
Netflix
NFLX
|
+$309M |
| 5 |
Emerson Electric
EMR
|
+$306M |
Sector Composition
| 1 | Technology | 23.54% |
| 2 | Healthcare | 14.5% |
| 3 | Consumer Discretionary | 11.23% |
| 4 | Financials | 9.56% |
| 5 | Communication Services | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KDNY
2201
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $343K | ﹤0.01% |
25,098
-56,805
| -69% | -$776K |
|
2202
PennyMac Financial
PFSI
$6.43B
| $341K | ﹤0.01% |
+15,428
| New | +$341K |
|
|
SILV
2203
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $341K | ﹤0.01% |
65,000
-78,300
| -55% | -$411K |
|
2204
Apollo Global Management
APO
$78B
| $340K | ﹤0.01% |
+10,160
| New | +$340K |
|
|
IBTX
2205
DELISTED
Independent Bank Group, Inc.
IBTX
| $340K | ﹤0.01% |
14,338
-24,725
| -63% | -$586K |
|
2206
OSI Systems
OSIS
$4.03B
| $338K | ﹤0.01% |
4,904
-17,293
| -78% | -$1.19M |
|
|
QADA
2207
DELISTED
QAD Inc.
QADA
| $338K | ﹤0.01% |
8,467
-2,912
| -26% | -$116K |
|
2208
Evertec
EVTC
$2.19B
| $337K | ﹤0.01% |
14,842
+7,117
| +92% | +$162K |
|
2209
Voyager Therapeutics
VYGR
$242M
| $336K | ﹤0.01% |
36,703
-153,303
| -81% | -$1.4M |
|
2210
Helix Energy Solutions
HLX
$932M
| $335K | ﹤0.01% |
204,607
+16,876
| +9% | +$27.6K |
|
|
BITA
2211
DELISTED
Bitauto Holdings Limited
BITA
| $335K | ﹤0.01% |
32,274
+2,975
| +10% | +$30.9K |
|
2212
Oportun Financial
OPRT
$279M
| $334K | ﹤0.01% |
31,628
-16,059
| -34% | -$170K |
|
|
ATNX
2213
DELISTED
Athenex, Inc. Common Stock
ATNX
| $333K | ﹤0.01% |
2,149
+844
| +65% | +$131K |
|
2214
United Rentals
URI
$61.8B
| $331K | ﹤0.01% |
3,220
+1,918
| +147% | +$197K |
|
2215
Viking Therapeutics
VKTX
$2.9B
| $331K | ﹤0.01% |
70,798
+57,257
| +423% | +$268K |
|
2216
Pathward Financial
CASH
$1.74B
| $330K | ﹤0.01% |
15,196
+2,340
| +18% | +$50.8K |
|
2217
Darling Ingredients
DAR
$5.05B
| $330K | ﹤0.01% |
+17,229
| New | +$330K |
|
|
ARR
2218
Armour Residential REIT
ARR
$1.72B
| $327K | ﹤0.01% |
7,423
+3,412
| +85% | +$150K |
|
|
TSC
2219
DELISTED
TriState Capital Holdings, Inc.
TSC
| $326K | ﹤0.01% |
33,678
-8,058
| -19% | -$78K |
|
|
SYKE
2220
DELISTED
SYKES Enterprises Inc
SYKE
| $325K | ﹤0.01% |
11,997
-9,562
| -44% | -$259K |
|
2221
CommScope
COMM
$3.67B
| $322K | ﹤0.01% |
35,313
-561,724
| -94% | -$5.12M |
|
2222
Commercial Vehicle Group
CVGI
$72.1M
| $321K | ﹤0.01% |
212,440
-23,018
| -10% | -$34.8K |
|
|
WIRE
2223
DELISTED
Encore Wire Corp
WIRE
| $321K | ﹤0.01% |
7,654
+1,733
| +29% | +$72.7K |
|
2224
Manitowoc
MTW
$363M
| $320K | ﹤0.01% |
37,593
+21,399
| +132% | +$182K |
|
2225
Columbus McKinnon
CMCO
$427M
| $319K | ﹤0.01% |
12,762
-7,703
| -38% | -$193K |
|